Dr. Lal PathLabs Ltd has announced that its Board of Directors has fixed Friday, December 19, 2025, as the record date for determining shareholder eligibility for its previously approved 1:1 bonus share issue. The update was communicated through a stock exchange filing on December 12.
The bonus issue—approved by shareholders on December 8—entitles investors to one fully paid-up equity share (face value ₹10) for every one existing equity share held as on the record date. The company noted that the deemed date of allotment for the bonus shares will be Monday, December 22, 2025, in line with SEBI guidelines.
The bonus shares will be issued to all eligible shareholders whose names appear on the Register of Members or in the list of beneficial owners as per NSDL and CDSL records.
This development is in accordance with Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and marks another corporate action from the diagnostics major aimed at enhancing liquidity for shareholders.
